Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Choosing points over cash rebates can lead to greater rewards, especially for travel enthusiasts. Find out why this option is beneficial.
27,389 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
When a company executive moves tens of thousands of shares, it sparks questions. This guide explains what insider sel...
In the demanding world of entertainment and performance, schedules are harsh and pay can be unpredictable. This artic...
A bold government push is reshaping quantum tech and investing. Learn which three big stocks are positioned to win, a...
SoFi stock down more this year, yet chief executive Anthony Noto has been buying shares. This article breaks down wha...
As AI memory roars, smart investors look beyond chips to the apps and components that unlock a new supercycle. This a...
Sandisk stock bounced back today as traders weighed memory price signals and broader tech trends. This guide breaks d...
Navitas Semiconductor, a noted Nvidia partner, posted a dramatic first-half surge in 2026 as its GaN and SiC power de...
When a chief executive sells stock, investors ask if the move is a red flag or a routine tax-related step. This piece...
Planning to use leveraged exposure to the S&P 500? This guide compares SPXL and SSO, explaining how each ETF magnifie...
Choosing the right global real estate ETF can boost income and diversification. This guide compares VNQI and REET, hi...
Healthcare investing comes in two main flavors: a market-weighted healthcare active manager approach and a more passi...